Updates in urologic oncology guidelines: urothelial carcinoma. A review

Abstract

Guidelines for drug therapy of urothelial cancer (UC) have had several significant updates since new data from clinical studies became available and due to updates of labels for certain drugs approved for this indication in the Russian Federation. Opinions of expert panels developing clinical guidelines of the Ministry of Health of Russia and practical guidelines of the Russian Society of Clinical Oncology (RUSSCO) were divided over several positions. The article presents the key points of these updates.